Van Beek Jeroen B

Chief Commercial Officer

1 company

Excellent

Trades Analyzed

12M Win Rate

95.8%

Avg 3M Return

+13.1%

Avg 12M Return

+57.9%

Van Beek Jeroen B is a Chief Commercial Officer at Kalaris Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 11 sells.

Estimated insider holdings value: $1.5M based on current market prices.

Holdings by Company

KLRSNov 16, 2022

Current Shares333.7K

Value$1.47M

Net Activity-275,170

Bought: 3.0KSold: 278.2K

Showing 10 filings

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Nov 16, 2022	KLRS Kalaris Therapeutics, Inc.	Chief Commercial Officer	Sell	16,074	$7.50	$120,527.67	-4.6%	-12.6%	-78.1%
Nov 11, 2022	KLRS Kalaris Therapeutics, Inc.	Chief Commercial Officer	Sell	36,592	$8.20	$299,904.37	-9.5%	-29.1%	-83.3%
Nov 10, 2022	KLRS Kalaris Therapeutics, Inc.	Chief Commercial Officer	Sell	13,408	$8.00	$107,292.84	-1.7%	-24.6%	-82.3%
Oct 19, 2022	KLRS Kalaris Therapeutics, Inc.	Chief Commercial Officer	Sell	1,070	$9.36	$10,015.95	-0.3%	-40.8%	-83.6%
Sep 2, 2022	KLRS Kalaris Therapeutics, Inc.	Chief Commercial Officer	Sell	493	$7.89	$3,889.18	-0.1%	-0.9%	-57.9%
Aug 16, 2022	KLRS Kalaris Therapeutics, Inc.	Chief Commercial Officer	Sell	15,590	$8.30	$129,473.39	-3.9%	+3.2%	-68.0%
Jul 20, 2022	KLRS Kalaris Therapeutics, Inc.	Chief Commercial Officer	Sell	1,058	$5.21	$5,516.94	-0.3%	+87.2%	-37.9%
Jun 3, 2022	KLRS Kalaris Therapeutics, Inc.	Chief Commercial Officer	Sell	515	$3.63	$1,870.53	-0.1%	+102.7%	+7.0%
May 17, 2022	KLRS Kalaris Therapeutics, Inc.	Chief Commercial Officer	Sell	15,262	$4.40	$67,166.54	-3.8%	+86.3%	-9.8%
Apr 20, 2022	KLRS Kalaris Therapeutics, Inc.	Chief Commercial Officer	Sell	852	$6.68	$5,695.02	-0.2%	-17.9%	-39.5%